Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;33(1):128-130.
doi: 10.1038/s41443-020-0311-z. Epub 2020 May 26.

Impact of treatment-related adverse events on efficacy of intralesional collagenase therapy for Peyronie's disease

Dyvon T Walker  1 , Robert H Shahinyan  1 , Arash Amighi  1 , Keith V Regets  1 , Jesse N Mills  1 , Sriram V Eleswarapu  2
Affiliations

Impact of treatment-related adverse events on efficacy of intralesional collagenase therapy for Peyronie's disease

Dyvon T Walker et al. Int J Impot Res. 2021 Jan.
No abstract available

PubMed Disclaimer

References

    1. Smith JF, Walsh TJ, Conti SL, Turek P, Lue T. Risk factors for emotional and relationship problems in Peyronie’s disease. J Sex Med. 2008;5:2179–84. - DOI
    1. Taylor FL, Levine LA. Peyronie’s Disease. Urol Clin N Am. 2007;34:517–34. - DOI
    1. Lipshultz LI, Goldstein I, Seftel AD, Kaufman GJ, Smith TM, Tursi JP, et al. Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie’s disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies. BJU Int. 2015;116:650–6. - DOI
    1. Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190:199–207. - DOI
    1. Amighi A, Mills SA, Eleswarapu SV, Regets KV, Mendhiratta N, Mills JN. A modified technique for intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease results in reduced procedural morbidity using a standardized hematoma classification rubric. World J Urol. 2020;38:293–8. - DOI

LinkOut - more resources